New Triple-Drug hair loss treatment enters final testing phase
Disease control
Recruiting now
This Phase 3 trial tests a new topical solution called TH07 for male pattern baldness. It combines three active ingredients (minoxidil, finasteride, and latanoprost) to see if it grows more hair than standard minoxidil or a placebo. 420 men aged 18-49 with moderate hair loss will…
Phase: PHASE3 • Sponsor: Triple Hair Inc • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC